Corey Davis | executive |
R. Struthers | executive |
Alan Krasner | executive |
Marc J. Wilson | executive |
Joseph Schwartz | analyst |
Yasmeen Rahimi | analyst |
Lee Hung | analyst |
James Hassard | executive |
Cory Jubinville | analyst |
Brian Skorney | analyst |
Douglas Tsao | analyst |
Jonathan Wolleben | analyst |
Yuchen Ding | analyst |
Leland Gershell | analyst |
Welcome to the Crinetics Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results Conference Call.[Operator Instructions]I will now turn the call over to Corey Davis of LifeSci Advisors. Please go ahead.
Thank you, Sergio, and hello, everyone.
Joining me on the call today are Scott Struthers, Founder and Chief Executive Officer; Alan Krasner, Chief Endocrinologist; and Marc Wilson, Chief Financial Officer. Also joining us for the Q&A portion of the call are Dana Pizzuti, Chief Medical and Development Officer; and Jim Hassard, Chief Commercial Officer.A press release announcing the fourth quarter and full year 2023 financial results was issued today and is also available on the Crinetics website.As a reminder, we'll be making forward-looking statements and I invite you to learn more about the risks and uncertainties associated with these statements, as disclosed in our SEC filings.